ZS expands agentic AI capabilities in ZAIDYN® for life sciences

The connected suite combines agentic AI with 40+ years of life sciences expertise to help teams plan faster, respond to market signals and automate workflows.

EVANSTON, Ill., Nov. 4, 2026 /PRNewswire/ -- ZS, a global management consulting and technology firm, today announced the expansion of agentic AI capabilities in ZAIDYN®, a connected suite of applications that combines advanced AI with ZS's more than 40 years of life sciences expertise. Designed for the demands of the highly regulated life sciences industry, ZAIDYN helps teams accelerate planning and insight generation, respond to market signals as they emerge and automate defined workflows—while keeping people in control of decisions that require human judgment.

Built in 2021 with AI at its core, ZAIDYN offers more than 30 modules used by life sciences companies, including 80% of the top 20, in over 100 countries. ZAIDYN now applies its new agentic capabilities across commercial, personalization, medical and patient workflows, with agents that can sense signals, analyze information, generate insights, recommend actions and automate approved activities within defined guardrails.

The evolution of ZAIDYN's agentic AI capabilities is already earning industry recognition, with Everest Group naming ZS a Luminary in its 2026 Innovation Watch: Agentic AI in Life Sciences Commercial assessment.

"Our clients are navigating declining HCP access, pricing pressures and more than $200 billion in sales facing loss of exclusivity, while simultaneously preparing for a promising pipeline of new launches," said Sunil Dixit, chief product officer at ZS. "AI offers a disruptive technology to respond to these market challenges. Now, with our new suite of agentic applications, ZAIDYN can help our clients leverage intelligence more quickly, so that their teams can accelerate commercialization and deepen engagement with patients and providers, while retaining the guardrails and human oversight a regulated industry like life sciences demands."

ZAIDYN is designed to deliver value from agentic AI in three ways:

• Accelerate planning and insight generation: Rapidly analyze data and information and help teams adjust plans as conditions change, shortening planning and decision cycles.
• Respond to market signals: Detect and interpret customer, competitor, patient and market signals and help determine and execute the appropriate next action.
• Automate workflows: Get recommended actions or ask agents to complete defined tasks within agreed controls, allowing experts to focus on decisions that require judgment.

Because ZAIDYN's applications are connected, they can also coordinate data, insights, decisions and actions across functions when the work requires it, helping organizations operate from a more complete understanding of their patients and healthcare providers.

ZAIDYN is a key part of ZS's strategy of helping organizations embed transformational AI into workflows and scale better decision-making across the enterprise. Designed to work with companies' existing technology foundations, including CRM, data lakehouse and other systems, ZAIDYN is supported by ZS from strategy and implementation through change management and ongoing operations. Organizations can choose to operate ZAIDYN themselves or have ZS operate it on their behalf.

Learn more about ZAIDYN's agentic innovations. 

About ZS
ZS is a management consulting and technology firm that partners with companies to improve life and how we live it. We transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 15,000 employees in over 40 offices worldwide. To learn more, visit ZS or follow ZS on LinkedIn.

Media contact
Maryam Ayromlou
Ruder Finn
ZS-RFMedia@ruderfinn.com
+1 703 474 5685

SOURCE ZS